Pulmonary hypertension in patients with chronic myeloproliferative disorders

Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertens...

Full description

Bibliographic Details
Main Authors: Yochai Adir, Davide Elia, Sergio Harari
Format: Article
Language:English
Published: European Respiratory Society 2015-09-01
Series:European Respiratory Review
Online Access:http://err.ersjournals.com/content/24/137/400.full
_version_ 1818491897197363200
author Yochai Adir
Davide Elia
Sergio Harari
author_facet Yochai Adir
Davide Elia
Sergio Harari
author_sort Yochai Adir
collection DOAJ
description Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertension for which the aetiology is unclear and/or multifactorial. The aim of this review is to discuss the epidemiology, pathogenic mechanism and treatment approaches of the more common forms of pulmonary hypertension in the context of CMPD's: chronic thromboembolic pulmonary hypertension, precapillary pulmonary hypertension and drug-induced PH.
first_indexed 2024-12-10T17:36:37Z
format Article
id doaj.art-7c8352d4ee48406487b71c9c0417233b
institution Directory Open Access Journal
issn 0905-9180
1600-0617
language English
last_indexed 2024-12-10T17:36:37Z
publishDate 2015-09-01
publisher European Respiratory Society
record_format Article
series European Respiratory Review
spelling doaj.art-7c8352d4ee48406487b71c9c0417233b2022-12-22T01:39:31ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172015-09-012413740041010.1183/16000617.0041-20150041-2015Pulmonary hypertension in patients with chronic myeloproliferative disordersYochai Adir0Davide Elia1Sergio Harari2 Pulmonary Division, Carmel Medical Center, Faculty of Medicine, Technion, Institute of Technology, Haifa, Israel U.O. di Pneumologia e Terapia Semi-Intensiva, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe, MultiMedica IRCSS, Milan, Italy U.O. di Pneumologia e Terapia Semi-Intensiva, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe, MultiMedica IRCSS, Milan, Italy Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertension for which the aetiology is unclear and/or multifactorial. The aim of this review is to discuss the epidemiology, pathogenic mechanism and treatment approaches of the more common forms of pulmonary hypertension in the context of CMPD's: chronic thromboembolic pulmonary hypertension, precapillary pulmonary hypertension and drug-induced PH.http://err.ersjournals.com/content/24/137/400.full
spellingShingle Yochai Adir
Davide Elia
Sergio Harari
Pulmonary hypertension in patients with chronic myeloproliferative disorders
European Respiratory Review
title Pulmonary hypertension in patients with chronic myeloproliferative disorders
title_full Pulmonary hypertension in patients with chronic myeloproliferative disorders
title_fullStr Pulmonary hypertension in patients with chronic myeloproliferative disorders
title_full_unstemmed Pulmonary hypertension in patients with chronic myeloproliferative disorders
title_short Pulmonary hypertension in patients with chronic myeloproliferative disorders
title_sort pulmonary hypertension in patients with chronic myeloproliferative disorders
url http://err.ersjournals.com/content/24/137/400.full
work_keys_str_mv AT yochaiadir pulmonaryhypertensioninpatientswithchronicmyeloproliferativedisorders
AT davideelia pulmonaryhypertensioninpatientswithchronicmyeloproliferativedisorders
AT sergioharari pulmonaryhypertensioninpatientswithchronicmyeloproliferativedisorders